Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

View All Favorites

A library of resources for the prevention,
management, and elimination of TB.

Filter your results

Clear All Filters

Showing 1 - 15 of 68 Results

Number of items to view

Filter Your Results

Category

Audience

Format

Language

Category

Audience

Format

Language

Title	Year
12-Dose Regimen for Latent TB Infection - Patient Education Materials The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events... Persons With LTBI Physicians	2018
Adherence to Long-Term Therapies: Evidence for Action This report provides a critical review of what is known about adherence to long-term therapies.This is achieved by looking beyond individual diseases. A broad range of policy options emerges by including communicable diseases such as tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), mental and neurological conditions such as depression and epilepsy, substance dependence (exemplified by smoking cessation), hypertension, asthma and palliative care for cancer. Managers and Supervisors Policy Makers	2003
An Activist’s Guide to Tuberculosis Drugs This guide provides a summary of safety and efficacy data for drugs currently in use to treat TB. The guide also suggests advocacy points for activists, clinicians, and others working in TB.	2016
Bedaquiline Dosage Charts .This job aid can be used by healthcare workers to view dosage information for bedaquiline. The resource also provides visual information for patients.	2017
Controlled Clinical Trials in Tuberculosis: A Guide for Multicentre Trials in High-Burden Countries 2004 This book is a guide for multi-center trials in high-burden countries.	2004
Development of New Drugs for TB Chemotherapy: Analysis of the Current Drug Pipeline This report provides an overview of various anti-TB medications. Lab Personnel	2006
DR-TB Drugs Under the Microscope This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price. International Agencies Policy Makers	2011
DR-TB Drugs Under the Microscope This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided. International Agencies Policy Makers	2016
DR-TB Drugs Under the Microscope This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price. International Agencies Policy Makers	2013
Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd edition This manual is a joint publication of the Curry International TB Center and the Tuberculosis Control Branch of the California Department of Public Health. The 10 chapters and 4 appendices cover major topics pertaining to epidemiology, diagnosis, laboratory issues, treatment, medications, pediatrics, co-morbidities and special situations, monitoring and case management, adverse reactions, and treatment of contacts.	2016
Fight AIDS. Fight TB. Fight Now. In this flash film, Winstone Zulu, a TB/HIV advocate from Zambia, says that TB is the leading killer of AIDS patients living in Africa. From his own experience of living with both AIDS and TB, and having been cured of TB himself, he states that there is a desperate need for TB patients to be treated with TB drugs, as TB can be cured... International Agencies	2004
Frequently Asked Questions About the 4-Drug Fixed-dose Combination Tablet Recommended by the World Health Organization for Treating Tuberculosis This booklet answers questions about the 4-drug fixed-dose combinations containing 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide, and 275 mg ethambutol that were added to the WHO Model List of Essential Drugs for the treatment of TB. International Agencies	2002
Handbook of Tuberculosis: Molecular Biology and Biochemistry The Handbook of Tuberculosis, which explores the causes and available treatments of the widespread infection as well as current research into vaccination, is divided into three separate volumes covering different areas of study. Each volume is a resource to molecular and cell biologists, bacteriologists, immunologists, pathologists and pathophysiologists, clinicians and those working in the pharmaceutical industry and interested in world health... Lab Personnel	2008
How to Take Your TB Medicine This resource provides information and general instructions for taking TB medicine. The patient's healthcare provider for TB treatment can write in treatment details. Persons With LTBI Persons with TB	2014
Improving TB Drug Management: Accelerating DOTS Expansion This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans. International Agencies Managers and Supervisors Policy Makers	2002

1
2
3
4
5